Director sold ~$836K of KRYS shares in the open market

Past results only. Not a forecast.

Record ID

0001298711-26-000009

Filed / recorded

Sep 4, 2026, 11:15 PM UTC

Added to OQRO

Oct 6, 2026, 7:59 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

Krystal Biotech, Inc.

Issuer CIK

1711279

Ticker

KRYS

Reporting person

Suma Krishnan

Relationship

Director, Officer, 10% owner

Officer title

President, R&D

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Sep 4, 2026

Transaction code

S

Shares / units

2,320

Price per share

$360.47

Acquired / disposed

Disposed (D)

Shares owned after

1,308,498

Ownership form

Direct

Amendment

No

1. The transaction was executed in multiple trades ranging from $360.01 to $361.005. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.